Jussi Mertsola

Author PubWeight™ 49.56‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 2009 2.36
2 Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J 2005 2.06
3 Immunity to pertussis 5 years after booster immunization during adolescence. Clin Infect Dis 2007 1.77
4 Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio 2014 1.76
5 Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 2011 1.74
6 Bordetella holmesii DNA is not detected in nasopharyngeal swabs from Finnish and Dutch patients with suspected pertussis. J Med Microbiol 2006 1.69
7 Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland. Clin Vaccine Immunol 2012 1.50
8 Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microbes Infect 2005 1.36
9 Factors contributing to pertussis resurgence. Future Microbiol 2008 1.35
10 Bordetella pertussis protein pertactin induces type-specific antibodies: one possible explanation for the emergence of antigenic variants? J Infect Dis 2003 1.29
11 Strain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 years. J Clin Microbiol 2005 1.28
12 Comparative genomics of Bordetella pertussis reveals progressive gene loss in Finnish strains. PLoS One 2007 1.26
13 Bordetella pertussis, Finland and France. Emerg Infect Dis 2006 1.05
14 Rhinovirus infections in children: a retrospective and prospective hospital-based study. J Med Virol 2009 1.05
15 Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis. J Clin Microbiol 2007 1.04
16 Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories. Vaccine 2006 1.04
17 Bordetella pertussis isolates in Finland: serotype and fimbrial expression. BMC Microbiol 2008 1.02
18 Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries. Infect Genet Evol 2011 1.01
19 Ultrasonography after the first febrile urinary tract infection in children. Eur J Pediatr 2006 0.97
20 Nasopharyngeal bacterial colonization and gene polymorphisms of mannose-binding lectin and toll-like receptors 2 and 4 in infants. PLoS One 2011 0.96
21 SNP-based typing: a useful tool to study Bordetella pertussis populations. PLoS One 2011 0.93
22 Comparison of total white blood cell count and serum C-reactive protein levels in confirmed bacterial and viral infections. J Pediatr 2006 0.90
23 Rapid typing of Bordetella pertussis pertussis toxin gene variants by LightCycler real-time PCR and fluorescence resonance energy transfer hybridization probe melting curve analysis. J Clin Microbiol 2002 0.89
24 Pertussis before and after the introduction of acellular pertussis vaccines in Finland. Vaccine 2009 0.89
25 Gene polymorphism in toll-like receptor 4: effect on antibody production and persistence after acellular pertussis vaccination during adolescence. J Infect Dis 2012 0.88
26 Pertussis immunization in the global pertussis initiative European region: recommended strategies and implementation considerations. Pediatr Infect Dis J 2005 0.88
27 Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection. Vaccine 2012 0.87
28 Interactions between Bordetella pertussis and the complement inhibitor factor H. Mol Immunol 2010 0.87
29 Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009. J Clin Microbiol 2012 0.86
30 PFGE and pertactin gene sequencing suggest limited genetic variability within the Finnish Bordetella parapertussis population. J Med Microbiol 2003 0.85
31 Antibody responses to defined regions of the Bordetella pertussis virulence factor pertactin. Scand J Infect Dis 2008 0.85
32 Clinical response to antibiotic therapy for community-acquired pneumonia. Eur J Pediatr 2004 0.84
33 Anti-diphtheria antibody seroprotection rates are similar 10 years after vaccination with dTpa or DTPa using a mathematical model. Vaccine 2004 0.83
34 Recurrent antibiotic use in a small child and the effects on the family. Scand J Prim Health Care 2004 0.83
35 Infantile pertussis rediscovered in China. Emerg Infect Dis 2002 0.82
36 Bordetella pertussis isolates, Finland. Emerg Infect Dis 2005 0.81
37 Symptoms and signs of community-acquired pneumonia in children. Scand J Prim Health Care 2003 0.81
38 Local immune response to upper urinary tract infections in children. Clin Vaccine Immunol 2008 0.81
39 Discrepancy between total white blood cell counts and serum C-reactive protein levels in febrile children. Scand J Infect Dis 2007 0.81
40 Toll-like receptor 2 subfamily gene polymorphisms are associated with Bacillus Calmette-Guérin osteitis following newborn vaccination. Acta Paediatr 2015 0.80
41 Increased risk of pertussis in adult patients with mannose-binding lectin deficiency. APMIS 2012 0.80
42 The Gene Polymorphism of IL-17 G-152A is Associated with Increased Colonization of Streptococcus pneumoniae in Young Finnish Children. Pediatr Infect Dis J 2015 0.80
43 Risk of repeated Moraxella catarrhalis colonization is increased in children with Toll-like receptor 4 Asp299Gly polymorphism. Pediatr Infect Dis J 2013 0.78
44 Interferon-gamma-dependent Immunity in Bacillus Calmette-Guérin Vaccine Osteitis Survivors. Pediatr Infect Dis J 2016 0.77
45 [Empyema--increasingly common complication connected to pneumonia in children]. Duodecim 2004 0.76
46 Pandemic influenza A (H1N1) virus in households with young children. Influenza Other Respir Viruses 2011 0.76
47 No evidence of cross-reactivity of human antibodies to a 33-mer peptide of the alpha-gliadin component of gluten with Bordetella pertussis pertactin. Vaccine 2005 0.75
48 [Evaluation of a feverish child]. Duodecim 2009 0.75
49 Association of MBL2, TLR1, TLR2, and TLR6 Polymorphisms with Production of IFN-γ and IL-12 in BCG Osteitis Survivors. Pediatr Infect Dis J 2016 0.75
50 [Lymphadenitis caused by nontuberculous mycobacteriae]. Duodecim 2011 0.75
51 [From continuing medical education to continuous professional development of pediatricians]. Duodecim 2003 0.75
52 Somatic factors at 8 years of age in children with recurrent use of antibiotics in early infancy. Acta Paediatr 2005 0.75
53 Burden of Recurrent Respiratory Tract Infections in Children: A Prospective Cohort Study. Pediatr Infect Dis J 2016 0.75
54 Polymorphisms of Mannose-binding Lectin and Toll-like Receptors 2, 3, 4, 7 and 8 and the Risk of Respiratory Infections and Acute Otitis Media in Children. Pediatr Infect Dis J 2017 0.75
55 [Not Available]. Duodecim 2006 0.75
56 [Use of pad gives accuracy to the diagnosis of urinary tract infections in children]. Duodecim 2006 0.75